Efficacy, Safety, and Tolerability in the treatment of Irritable Bowel Syndrome with Diarrhea

IBS Self Help and Support Group Forums - IBSgroup.org: Efficacy, Safety, and Tolerability in the treatment of Irritable Bowel Syndrome with Diarrhea - IBS Self Help and Support Group Forums - IBSgroup.org

Woman in stomach pain, http://www.nlm.nih.gov/medlineplus/images/stomacheache.jpg, Copyright: U.S. National Library of Medicine, National Institute of Health

Latest Poll: Do you recall experiencing abdominal pain during your childhood?

Irritable Bowel Syndrome Research Studies:

Medical researchers are continuously searching for new or better ways to treat illness or disease. If they discover something that may be helpful, it cannot be put into general use until years of careful testing has been done. Research studies are what enable medical research for a drug to, in turn, become available to physicians and patients. Research studies may also be referred to as clinical studies, clinical trials, drug trials or drug studies. Read Understanding Research Studies for further information.

Research subjects are needed for the following posted studies.

If you are the Primary Investigator and have a research study that you would like posted, please contact us.

http://www.ibsgroup.org/images/rss.gif http://www.ibsgroup.org/images/xml-rss-2.0.gif

Page 1 of 1

You cannot start a new topic
You cannot reply to this topic

Efficacy, Safety, and Tolerability in the treatment of Irritable Bowel Syndrome with Diarrhea Allegiant Clinical Research in Houston, Texas

#1 Help Crohns/Colitis/IBS

New Member

Group: Members
Posts: 1
Joined: 12-July 10
City:Houston
Country:United States

Posted 12 July 2010 - 11:11 AM

Efficacy, Safety, and Tolerability in the treatment of Irritable Bowel Syndrome with Diarrhea

Details: The purpose of this study is to determine the efficacy, safety, and tolerability of different doses of JNJ-27018966 compared with placebo in the treatment of patients with irritable bowel syndrome with diarrhea (IBS-d).

Ages Eligible for the Study: 18 - 65 yrs old
Genders Eligible for the Study: Male and Females
Contact Information:

Allegiant Clinical Research
Ana Laura Gutierrez, CRC.
analgutierrez@allegiantcr.com
5420 Dashwood suite 302
Houston Tx. 77081
P: 832-380-8180
F: 713432-1283

Principal Investigator: Alfredo Gueler MD.